Pulmonary Outcomes Within a 2-Year Period in Subjects With Diabetes Mellitus Treated With Technosphere /Insulin or Usual Antidiabetic Treatment and in Subjects Without Abnormalities in Glucose Control.
Phase of Trial: Phase III
Latest Information Update: 03 Oct 2018
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors MannKind Corporation
- 03 Oct 2018 According to a MannKind Corporation media release, data were presented at the 54th Annual Meeting of the European Association for the Study of Diabetes (EASD).
- 31 Aug 2018 Biomarkers information updated
- 16 Aug 2013 Planned number of patients changed to 2343.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History